Back to Search
Start Over
Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases
- Source :
- Alimentary Pharmacology & Therapeutics. 45:1370-1371
- Publication Year :
- 2017
- Publisher :
- Wiley, 2017.
- Subjects :
- 030203 arthritis & rheumatology
medicine.medical_specialty
Hepatology
Tumor Necrosis Factor-alpha
business.industry
Gastroenterology
Antibodies, Monoclonal
Inflammatory Bowel Diseases
Biosimilar
Infliximab
03 medical and health sciences
0302 clinical medicine
Text mining
Internal medicine
medicine
Humans
030211 gastroenterology & hepatology
Pharmacology (medical)
Anti-tumour necrosis factor alpha agent
business
Biosimilar Pharmaceuticals
medicine.drug
Subjects
Details
- ISSN :
- 02692813
- Volume :
- 45
- Database :
- OpenAIRE
- Journal :
- Alimentary Pharmacology & Therapeutics
- Accession number :
- edsair.doi.dedup.....70f0cc8651bbd9cf525973f80247027b
- Full Text :
- https://doi.org/10.1111/apt.14050